Rachel A. Davis

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Stanford University

Rachel A. Davis is an author at Dana-Farber Cancer Institute specializing in synaptic transmission, cdk inhibitors, and cyclin-dependent kinase inhibitors.

Publications per year

2023–2025

Publications

Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis

Solomiia Savchuk, Kaylee M. Gentry, Wengang Wang et al. · Nature · 2025 · 48 citations · Full text

Medicine, Neurobiology, Oncology +16

USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities

Naiara Perurena, Rebecca Lock, Rachel A. Davis et al. · Cell Reports Medicine · 2023 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–2 of 2